Jeff Yass’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$160K Sell
17,591
-57,838
-77% -$584K ﹤0.01% 12174
2026
Q2
$860K Buy
75,429
+46,940
+165% +$465K ﹤0.01% 8581
2026
Q1
$262K Buy
28,489
+11,460
+67% +$95.4K ﹤0.01% 11162
2025
Q4
$127K Buy
+17,029
New +$117K ﹤0.01% 11310
2025
Q3
– Sell
-44,747
Closed -$309K – 14007
2025
Q2
$309K Sell
44,747
-5,638
-11% -$38.3K ﹤0.01% 10274
2025
Q1
$367K Buy
50,385
+23,547
+88% +$185K ﹤0.01% 9613
2024
Q4
$215K Buy
26,838
+16,158
+151% +$140K ﹤0.01% 10569
2024
Q3
$78.3K Buy
+10,680
New +$76.3K ﹤0.01% 11183
2024
Q1
– Sell
-17,675
Closed -$139K – 13435
2023
Q4
$139K Buy
+17,675
New +$128K ﹤0.01% 11043
2023
Q3
– Sell
-26,764
Closed -$262K – 13073
2023
Q2
$262K Sell
26,764
-185,129
-87% -$1.88M ﹤0.01% 9714
2023
Q1
$2.05M Buy
211,893
+184,501
+674% +$1.61M ﹤0.01% 5084
2022
Q4
$207K Buy
+27,392
New +$185K ﹤0.01% 10038
2022
Q3
– Sell
-46,012
Closed -$295K – 14196
2022
Q2
$248K Buy
46,012
+34,846
+312% +$188K ﹤0.01% 10088
2022
Q1
$56K Buy
+11,166
New +$51.8K ﹤0.01% 12267

Other funds holding VMD

Jeff Yass's VMD Position: Q3 2026 in Review

Jeff Yass reduced its Viemed Healthcare (VMD) stake by 77% in Q3 2026, selling an estimated $584K and leaving 17,591 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #12174.

Jeff Yass first reported a position in VMD in Q1 2022 and has held it in 14 quarters since. The position peaked at $2.05M in Q1 2023. 162 funds tracked by Wall St. Rank hold VMD as of Q3 2026.

  • Jeff Yass held 17,591 shares of Viemed Healthcare worth $160K as of Q3 2026.
  • Jeff Yass sold 57,838 Viemed Healthcare shares in Q3 2026, an estimated $584K.
  • Viemed Healthcare made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12174 holding.
  • Jeff Yass first reported a position in Viemed Healthcare in Q1 2022 and has held it in 14 quarters since.
  • Jeff Yass's Viemed Healthcare position peaked at $2.05M in Q1 2023.
  • 162 funds tracked by Wall St. Rank held Viemed Healthcare as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.